TRPA1 channel mediates methylglyoxal-induced mouse bladder dysfunction

Introduction: The transient receptor potential ankyrin 1 channel (TRPA1) is expressed in urothelial cells and bladder nerve endings. Hyperglycemia in diabetic individuals induces accumulation of the highly reactive dicarbonyl compound methylglyoxal (MGO), which modulates TRPA1 activity. Long-term or...

Full description

Bibliographic Details
Main Authors: Akila L. Oliveira, Matheus L. Medeiros, Erick de Toledo Gomes, Glaucia Coelho Mello, Soraia Katia Pereira Costa, Fabíola Z. Mónica, Edson Antunes
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2023.1308077/full
_version_ 1797400659381714944
author Akila L. Oliveira
Matheus L. Medeiros
Erick de Toledo Gomes
Glaucia Coelho Mello
Soraia Katia Pereira Costa
Fabíola Z. Mónica
Edson Antunes
author_facet Akila L. Oliveira
Matheus L. Medeiros
Erick de Toledo Gomes
Glaucia Coelho Mello
Soraia Katia Pereira Costa
Fabíola Z. Mónica
Edson Antunes
author_sort Akila L. Oliveira
collection DOAJ
description Introduction: The transient receptor potential ankyrin 1 channel (TRPA1) is expressed in urothelial cells and bladder nerve endings. Hyperglycemia in diabetic individuals induces accumulation of the highly reactive dicarbonyl compound methylglyoxal (MGO), which modulates TRPA1 activity. Long-term oral intake of MGO causes mouse bladder dysfunction. We hypothesized that TRPA1 takes part in the machinery that leads to MGO-induced bladder dysfunction. Therefore, we evaluated TRPA1 expression in the bladder and the effects of 1 h-intravesical infusion of the selective TRPA1 blocker HC-030031 (1 nmol/min) on MGO-induced cystometric alterations.Methods: Five-week-old female C57BL/6 mice received 0.5% MGO in their drinking water for 12 weeks, whereas control mice received tap water alone.Results: Compared to the control group, the protein levels and immunostaining for the MGO-derived hydroimidazolone isomer MG-H1 was increased in bladders of the MGO group, as observed in urothelium and detrusor smooth muscle. TRPA1 protein expression was significantly higher in bladder tissues of MGO compared to control group with TRPA1 immunostaining both lamina propria and urothelium, but not the detrusor smooth muscle. Void spot assays in conscious mice revealed an overactive bladder phenotype in MGO-treated mice characterized by increased number of voids and reduced volume per void. Filling cystometry in anaesthetized animals revealed an increased voiding frequency, reduced bladder capacity, and reduced voided volume in MGO compared to vehicle group, which were all reversed by HC-030031 infusion.Conclusion: TRPA1 activation is implicated in MGO-induced mouse overactive bladder. TRPA1 blockers may be useful to treat diabetic bladder dysfunction in individuals with high MGO levels.
first_indexed 2024-03-09T01:57:43Z
format Article
id doaj.art-6371fc431122426d87c22a0f69c00273
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-03-09T01:57:43Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-6371fc431122426d87c22a0f69c002732023-12-08T12:25:14ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2023-12-011410.3389/fphys.2023.13080771308077TRPA1 channel mediates methylglyoxal-induced mouse bladder dysfunctionAkila L. Oliveira0Matheus L. Medeiros1Erick de Toledo Gomes2Glaucia Coelho Mello3Soraia Katia Pereira Costa4Fabíola Z. Mónica5Edson Antunes6Department of Pharmacology, University of Campinas (UNICAMP), São Paulo, BrazilDepartment of Pharmacology, University of Campinas (UNICAMP), São Paulo, BrazilDepartment of Pharmacology, University of Campinas (UNICAMP), São Paulo, BrazilDepartment of Pharmacology, University of Campinas (UNICAMP), São Paulo, BrazilDepartment of Pharmacology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, BrazilDepartment of Pharmacology, University of Campinas (UNICAMP), São Paulo, BrazilDepartment of Pharmacology, University of Campinas (UNICAMP), São Paulo, BrazilIntroduction: The transient receptor potential ankyrin 1 channel (TRPA1) is expressed in urothelial cells and bladder nerve endings. Hyperglycemia in diabetic individuals induces accumulation of the highly reactive dicarbonyl compound methylglyoxal (MGO), which modulates TRPA1 activity. Long-term oral intake of MGO causes mouse bladder dysfunction. We hypothesized that TRPA1 takes part in the machinery that leads to MGO-induced bladder dysfunction. Therefore, we evaluated TRPA1 expression in the bladder and the effects of 1 h-intravesical infusion of the selective TRPA1 blocker HC-030031 (1 nmol/min) on MGO-induced cystometric alterations.Methods: Five-week-old female C57BL/6 mice received 0.5% MGO in their drinking water for 12 weeks, whereas control mice received tap water alone.Results: Compared to the control group, the protein levels and immunostaining for the MGO-derived hydroimidazolone isomer MG-H1 was increased in bladders of the MGO group, as observed in urothelium and detrusor smooth muscle. TRPA1 protein expression was significantly higher in bladder tissues of MGO compared to control group with TRPA1 immunostaining both lamina propria and urothelium, but not the detrusor smooth muscle. Void spot assays in conscious mice revealed an overactive bladder phenotype in MGO-treated mice characterized by increased number of voids and reduced volume per void. Filling cystometry in anaesthetized animals revealed an increased voiding frequency, reduced bladder capacity, and reduced voided volume in MGO compared to vehicle group, which were all reversed by HC-030031 infusion.Conclusion: TRPA1 activation is implicated in MGO-induced mouse overactive bladder. TRPA1 blockers may be useful to treat diabetic bladder dysfunction in individuals with high MGO levels.https://www.frontiersin.org/articles/10.3389/fphys.2023.1308077/fullurotheliumlamina propriacystometryvoid spot assayMG-H1glyoxalase
spellingShingle Akila L. Oliveira
Matheus L. Medeiros
Erick de Toledo Gomes
Glaucia Coelho Mello
Soraia Katia Pereira Costa
Fabíola Z. Mónica
Edson Antunes
TRPA1 channel mediates methylglyoxal-induced mouse bladder dysfunction
Frontiers in Physiology
urothelium
lamina propria
cystometry
void spot assay
MG-H1
glyoxalase
title TRPA1 channel mediates methylglyoxal-induced mouse bladder dysfunction
title_full TRPA1 channel mediates methylglyoxal-induced mouse bladder dysfunction
title_fullStr TRPA1 channel mediates methylglyoxal-induced mouse bladder dysfunction
title_full_unstemmed TRPA1 channel mediates methylglyoxal-induced mouse bladder dysfunction
title_short TRPA1 channel mediates methylglyoxal-induced mouse bladder dysfunction
title_sort trpa1 channel mediates methylglyoxal induced mouse bladder dysfunction
topic urothelium
lamina propria
cystometry
void spot assay
MG-H1
glyoxalase
url https://www.frontiersin.org/articles/10.3389/fphys.2023.1308077/full
work_keys_str_mv AT akilaloliveira trpa1channelmediatesmethylglyoxalinducedmousebladderdysfunction
AT matheuslmedeiros trpa1channelmediatesmethylglyoxalinducedmousebladderdysfunction
AT erickdetoledogomes trpa1channelmediatesmethylglyoxalinducedmousebladderdysfunction
AT glauciacoelhomello trpa1channelmediatesmethylglyoxalinducedmousebladderdysfunction
AT soraiakatiapereiracosta trpa1channelmediatesmethylglyoxalinducedmousebladderdysfunction
AT fabiolazmonica trpa1channelmediatesmethylglyoxalinducedmousebladderdysfunction
AT edsonantunes trpa1channelmediatesmethylglyoxalinducedmousebladderdysfunction